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total fast of approximately 150 days! This impressive
energy reserve is due both to the high energy content
of triglycerides versus polysaccharides, and the fact
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that triglycerides are stored in essentially anhydrousHarvard Medical School
form; polysaccharides such as glycogen are hydratedBoston, Massachusetts 02115
in storage form, decreasing their efficiency as fuel.†Beth Israel Deaconess Medical Center
To understand obesity, one must understand the con-Division of Endocrinology and the Department
cept of energy balance (Figure 1). Assuming that anof Medicine
individual has no problem with the absorption of nutri-Harvard Medical School
ents, stored energy will increase only if energy intakeBoston, Massachusetts 02115
exceeds total body energy expenditure. Energy expen-
diture takes the form of physical activity, basal metabo-
lism, and adaptive thermogenesis. Physical activity re-
Obesity is defined medically as a state of increased body fers to all voluntary movement, while basal metabolism
weight, more specifically adipose tissue, of sufficient refers to the myriad biochemical processes necessary
magnitude to produce adverse health consequences. to sustain life. Adaptive thermogenesis refers to energy
There has been an alarming increase recently in the dissipated in the form of heat in response to environ-
prevalence of this heterogeneous group of disorders in mental changes, such as exposure to cold and alter-
the Western world (Kuczmarski et al., 1994). Fully one- ations in diet. It should be pointed out that the boundary
third of the American population is now considered between what is considered basal metabolism versus
obese, and the prevalence of obesity in children is esca- adaptive thermogenesis is not always clear-cut. Mam-
lating dramatically, presaging even greater medical mals often live in climates with temperatures below body
harm in the decades to come (Troiano and Flegal, 1999). temperature, sometimes far below body temperature.
What accounts for this epidemic of energy storage? Thus, the determination of energy expenditure in re-
Body weight and composition, and the storage of energy sponse to cold versus that which is considered part of
as triglyceride in adipose tissue, are determined by the basal metabolism can be quite arbitrary. Traditionally,
interaction between genetic, environmental, and psy- the basal metabolism rate is defined as the energy ex-
chosocial factors. These influences ultimately act by penditure of a subject relaxed and at rest, at thermoneu-
changing the energy balance equation, that is, the long- trality, 8–12 hr after the last food ingestion. Metabolic
term balance between energy intake and expenditure. rates of mammals will obviously vary as a continuum
Physiologic studies had previously suggested that body depending upon precise environmental conditions to
weight and energy stores are homeostatically regulated, which the organism is exposed.
with either weight loss or gain producing concerted Various cellular events can generally cause or prevent
changes in energy intake and expenditure that resist the obesity only if they affect the overall energy equation of
initial perturbation. Recent cloning of several obesity the individual. For example, absent the concept of en-
genes has revealed the initial molecular components of ergy balance, it might be supposed that obesity and its
a coherent physiologic system for energy homeostasis complications could be ameliorated by directly limiting
(Barsh et al., 2000). Studies of obesity pathogenesis adipose tissue development. Experimental models in
must now attempt to explain the disorder in the context which fat cell differentiation, development, and survival
of this physiologic system. have been directly reduced have shown that this is not
Although the role of genes in body fat regulation is the case. Far from creating healthy, lean mice, the re-
now established, it is safe to assume that the rising sulting animals appear to suffer from lack of an appro-
priate depot in which to deposit excess energy, and lossprevalence of obesity has not been due to a recent
of key adipocyte-derived hormones (Ross et al., 1993;change in the genetics of the Western world. The pro-
Moitra et al., 1998; Shimomura et al., 1998). This resultspensity for obesity must have been in our midst for a
in increased levels of blood lipids, accumulation of fatlong time, only to emerge recently on a large scale as
in the liver, diabetes, and death. Conversely, when aa result of changes in the environment, in particular
genetically altered animal is found to be leaner, this doesthe availability and composition of food and reduced
not necessarily imply that the targeted gene has a rolerequirement for physical exertion. It is very likely that
in fat development, per se. Rather, a defect is created inthe ability to store fat in times of nutritional abundance
some component in the total energy balance scheme—was a positive trait selected over many thousands of
usually food intake or energy expenditure.years of human evolution. The idea that humans evolved
A precise understanding of the contribution of diet toto efficiently store excess energy as fat to deal with
obesity has been confounded by the difficulty of ob-periodic famine has been given a name — the “thrifty
taining accurate measurements of food intake in free-gene” hypothesis (Neel, 1999). An obese human of ap-
living individuals. Obese individuals tend to underreportproximately 250 lbs. has the energy stores to survive a
food intake by as much as 30% (Lichtman et al., 1992),
and most obese individuals are believed to ingest more
calories than lean individuals (matched for exercise and‡ E-mail: bruce_spiegelman@dfci.harvard.edu (B. M. S.); jflier@
caregroup.harvard.edu (J. S. F.). other features), to maintain their increased weights.
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of feeding behavior may be divided into short- and long-
term control systems. Short-term control involves the
initiation and termination of meals. The major determi-
nant of meal size is the onset of satiety, a response to
neural and endocrine factors, such as gut distension
and release of the gut peptide cholecystokinin (CCK)
Figure 1. Key Component of the Energy Balance System
that are generated during the course of meal ingestion
Obesity develops only if energy intake, in the form of feeding, chroni-
(Moran, 2000). These signals are transmitted to the cau-cally exceeds total body expenditure. Energy expenditure includes
dal brainstem via the vagus nerve, where integrationphysical activity, basal metabolism, and adaptive thermogenesis.
with other inputs occurs, leading to meal termination.
Regulation of individual meal size by factors induced
by meal ingestion is insufficient to account for energyApart from the obvious effect of availability of palatable
balance over long periods of time since mice repeatedlyfoods, the study of the influence of macronutrient com-
injected with CCK maintain weight by ingesting moreposition, such as the balance of protein, carbohydrate,
meals of smaller size. Long-term signals that reflect theand fat on long-term body weight is in its infancy, and
status of energy stores, such as the fat-derived hormonegene–diet interactions in the feeding response to diets
leptin, provide information to the CNS that further regu-of varying composition are just beginning to be studied.
lates feeding behavior to promote energy homeostasis.Because of the central notion of energy balance, food
Not surprisingly, these short- and long-term systems areintake can be thought of as inadequate or excessive only
interrelated (Emond et al., 1999), such that the feedingin the context of that individual’s energy expenditure.
response to energy deficit is accomplished predomi-It is clear that different individuals have a certain ge-
nantly through increased meal size.netic propensity to store excessive caloric intake as fat.
Role of the HypothalamusIn a classic study, Bouchard and collaborators overfed
The hypothalamus is a region of the brain critical forpairs of monozygotic twins by precisely calibrated
regulation of homeostatic processes such as feeding,amounts (Bouchard et al., 1990). Different sets of twins
thermoregulation, and reproduction (Elmquist et al.,showed remarkable differences in the degree to which
1999). To accomplish these ends, the hypothalamusthese calories were stored as fat, but the tendency to-
senses neural, endocrine, and metabolic signals, inte-ward increased adiposity within each set of twins was
grates these inputs, and engages distinct effector path-remarkably similar. Since overfeeding above basal needs
ways, resulting in behavioral, autonomic, and endocrinewas controlled, the likely difference in fat accretion be-
responses. In addition to the hypothalamus, central con-tween sets of twins was likely due to differences in
trol of appetite and energy balance clearly involvessome component of energy expenditure, perhaps basal
widely distributed neural systems in the brainstem, cere-metabolic rates or adaptive thermogenesis. Further evi-
bral cortex, olfactory areas, and elsewhere. The centraldence that differences in metabolic rate are important
role of the hypothalamus in appetite and satiety wasvariables in human obesity is provided by prospective
determined early on by lesion studies. Lesions in thestudies done in Pima Indians (Ravussin, 1995), a group
ventromedial hypothalamus cause obesity, while lesions
of Native Americans with a high predilection for obesity.
in the lateral hypothalamus cause leanness (Elmquist et
When individuals were typed as to metabolic rates and
al., 1999). The inherent crudeness of physical lesions
then followed, those with lower metabolic rates had a and the absence of defined molecular and anatomic
greater incidence and magnitude of obesity. pathways underlying them limited the interpretation of
this paradigm, however, and other approaches were
CNS Control of Energy Intake and Body Weight taken. For example, the effects of centrally administered
The central nervous system (CNS) influences energy neurotransmitters such as norepinephrine, dopamine,
balance and body weight through three mechanisms: and serotonin, and hypothalamic neuropeptides such
(1) effects on behavior, including feeding and physical as NPY and CRH on food intake, autonomic output,
activity; (2) effects on autonomic nervous system activ- metabolism, and energy balance were assessed. These
ity, which regulates energy expenditure and other as- studies established the existence of several CNS ligand-
pects of metabolism; and (3) effects on the neuroendo- receptor pathways capable of modifying energy intake,
crine system, including secretion of hormones such as energy balance, and metabolic status.
growth hormone, thyroid, cortisol, insulin, and sex ste- Early Studies of NPY
roids. The identity and coordination of these complex Examination of the neuropeptide Y (NPY) pathway best
systems has been the subject of intense study, and exemplifies such studies. NPY is widely and abundantly
much recent progress. expressed within the nervous system. The arcuate nu-
Regulation of Energy Intake: Short- cleus of the hypothalamus is one site of particularly
and Long-Term Control dense expression, and nutritional regulation (increased
Feeding behavior lies at the interface between free will with starvation) is uniquely observed at that site. When
and physiology, and is influenced by many factors. In administered into cerebral ventricles or specific hypo-
addition to food availability, feeding is affected by meta- thalamic nuclei, NPY robustly and rapidly increases feed-
bolic, neural, and endocrine factors, and is modified ing and suppresses energy expenditure, and thereby
by powerful visual, olfactory, emotional, and cognitive promotes obesity (Stanley et al., 1986; Billington et al.,
inputs. Ultimately, all of these factors must be inte- 1994). NPY was therefore viewed as an excellent candi-
grated, so that decisions to begin and end periods of date for an endogenous regulator of energy balance,
promoting anabolism in response to energy deficits. Thefeeding will result (Schwartz et al., 2000). The regulation
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biggest gap in knowledge regarding NPY, and the many (Ahima et al., 1996). Reduced leptin entrains a complex
neural response characteristic of starvation that in-other neurochemicals similarly shown to stimulate or
suppress feeding, was our limited understanding of the cludes hunger/food seeking behavior, efficient metabo-
lism (clearly demonstrated in rodents), and an array ofphysiologic system in which these powerful neural cir-
cuits participated. Specifically, how did nutritional sta- neuroendocrine responses that favor survival during pe-
riods of limited energy, such as suppression of reproduc-tus communicate information to these central pathways
for integration and control? One obvious candidate sig- tion, linear growth, and thyroid hormone levels (Ahima
et al., 1996). Reintroduction of energy supplies rapidlynal was the hormone insulin (Schwartz et al., 2000). Insu-
lin levels do reflect energy balance and stores, as they raises leptin levels and suppresses this starvation pro-
gram. Absence of the leptin signal in the presence offall with starvation and rise with obesity. Insulin is trans-
ported into the brain through a saturable process, and sufficient energy promotes obesity in both rodents and
humans by producing an internal perception of starva-when centrally administered, suppresses both food in-
take and arcuate NPY expression. However, the ab- tion in the midst of plenty. In addition to its actions
through CNS circuits, leptin appears to exert severalsence of insulin, as in type 1 diabetes, is associated
with weight loss rather than gain. Furthermore, evidence effects directly on peripheral tissues through leptin re-
ceptor signaling. One important effect may involve sup-that physiologic changes in peripheral insulin levels af-
fected energy balance through the brain was limited, pression of triglyceride accumulation in nonadipose tis-
sue, such as muscle and liver, which contributes toso most investigators believed that insulin was not the
dominant peripheral signal to the CNS for regulation of insulin resistance (Lee et al., 2000). Potent effects of
leptin have also been seen on the immune system, theenergy balance. That signal was yet to be discovered.
Monogenic Obesities and the Discovery of Leptin vascular system, and even on bone turnover (Ducy et
al., 2000). Although it clearly serves as the switch fromThe field of energy balance advanced rapidly with the
cloning of genetic loci responsible for several of the the starved to the fed states, leptin has limits in control-
ling obesity. As fat mass increases, further rises in leptinpreviously identified monogenic obesity syndromes in
mice. The most dramatic and consequential advance have a limited ability to suppress food intake and prevent
obesity, as seen by the prevalence of obesity despiteresulted from the identification of the basis for syn-
dromes of obesity in ob/ob and db/db mice (Zhang et high levels of circulating leptin (Considine et al., 1996).
Thus, the antiobesity role of leptin might have beenal., 1994; Chen et al., 1996). Prior studies used the tech-
nique of parabiosis, in which mice are surgically joined limited through evolutionary pressure to promote fat
storage in times of plenty.to permit passage of molecules from one to the other.
These led to the suggestion 30 years ago that ob/ob Central Neural Circuits Regulating
Energy Balancemice might be deficient in a circulating signal of satiety,
while db/db mice might be deficient in its cognate recep- Knowledge of the neural circuits that coordinate the
response to leptin and other inputs has increased at ator. This prescient prediction was fully born out with
cloning of these genes in 1994 and 1995. The ob gene rapid rate. Through positional cloning of rodent genes,
targeted gene deletion, identification of mutant genesencodes a unique member of the cytokine family now
named leptin, from the Greek root leptos, for thin. The in human obesity, and follow-up studies using the tech-
niques of functional neuroanatomy, a complex and ex-dominant site from which leptin is secreted is the adipo-
cyte, and the protein is truncated and biologically inac- tensive central circuit for regulation of energy balance
has been defined. Although several sites in the braintive in mutant mice (Zhang et al., 1994). The obesity
syndrome in ob/ob mice is corrected by administration express leptin receptors and respond to this hormone
and various neuropeptides with changes in energy in-of the missing hormone (Halaas et al., 1995; Friedman
and Halaas, 1998). Regulated expression of leptin in take and expenditure, the best characterized and most
clinically relevant circuit is simply described as a leptin-other sites, such as skeletal muscle (Wang et al., 1998),
placenta, and stomach has been reported, and may regulated central melanocortin circuit. The major com-
ponents of this circuit are presented in Figure 2, whereultimately be proven to be physiologically important,
although this is not yet established. The signaling form 7 unique proteins in a single pathway have been shown
to contribute to weight regulation and obesity.of the leptin receptor, ObRb, is deleted in db/db mice
(Chen et al., 1996; Friedman and Halaas, 1998), which The Central Melanocortin Pathway
Leptin acts through ObRb receptors on two distinct pop-are consequently unresponsive to endogenous or exog-
enous leptin. The identification of these two proteins ulations of neurons in the arcuate nucleus. One popula-
tion coexpresses the orexigenic (feeding-inducing) neu-establishes the first well-documented components of a
powerful nutritional feedback loop from adipose tissue ropeptides NPY and AgRP, and leptin action reduces
their expression (Elias et al., 1999; Elmquist et al., 1999;to the brain.
Leptin Physiology Schwartz et al., 2000). The other population coexpresses
mRNAs encoding anorexigenic peptides, cocaine andDespite the remarkable ability of leptin to reverse obe-
sity in leptin deficient ob/ob mice, and to cause leanness amphetamine related transcript (CART) and a-MSH (de-
rived from proopiomelanocortin [POMC]), and leptin in-in wild-type mice, the function of the leptin pathway
may not be simply understood as an antiobesity axis. duces their expression (Elias et al., 1999; Elmquist et
al., 1999; Schwartz et al., 2000). Thus, leptin suppressesIndeed, substantial data suggest that basal levels of
leptin in the fed state serve as a signal of energy suffi- two orexigenic peptides and induces two anorexigenic
peptides through direct action on arcuate neurons. Theciency (Reviewed in Ahima and Flier, 2000). Withdrawal
of the leptin signal occurs quite rapidly with food restric- pathway just described is incestuous, as AgRP and
a-MSH are antagonistic ligands for a common receptor,tion, exceeding the rate at which fat stores are reduced
Cell
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Figure 2. A Leptin-Regulated Melanocortin Circuit Influences Energy Homeostasis and Body Weight
The adipocyte hormone leptin crosses the blood brain barrier (BBB) and acts directly on two populations of neurons within the arcuate nucleus
that express NPY and AgRP or POMC and CART. Leptin stimulates production of a-MSH, an agonist for the MC4 receptor (as well as CART),
and inhibits production of AgRP, an antagonist for this receptor (as well as NPY). MC4 receptor–expressing neurons receive these leptin-
regulated signals, as well as others, such as NPY. Such MC4R neurons are just now being chemically and functionally identified, and include
TRH neurons in the paraventricular nucleus (PVH) that regulate the thyroid, MCH neurons in the lateral hypothalamus that regulate feeding,
GABAergic neurons in the PVH that modify other as yet unidentified neurons tied into energy balance, and others. Several outputs of the
MC4R-expressing neurons include: endocrine outputs such as thyroid, growth and reproduction, through control of pituitary function; behavioral
outputs, including feeding; autonomic output, regulating energy expenditure; insulin secretion; and glucose homeostasis. Sites in the pathway
at which spontaneous loss of function mutations have caused obesity in rodents and humans are indicated in yellow, as are sites at which
induced mutations have caused obesity in rodents (in blue). Not shown here are potential direct actions of leptin on peripheral tissues.
the melanocortin 4 receptor (MC4R), which is expressed ative mechanism (Farooqi et al., 2000). This suggests
that this pathway is required for normal energy homeo-primarily in the brain (Cone, 1999). Activation of MC4R by
MSH reduces food intake, while suppression of MC4R stasis and is extremely tightly regulated. The obesity in
several other rare human and murine syndromes alsosignaling through this receptor by the endogenous an-
tagonist AgRP or pharmacologic antagonists increases converges on this pathway. For example, mutation in
the POMC gene, which prevents production of POMCfeeding and diminishes the hypophagic response to leptin
(Fan et al., 1997). This pathway was discovered through products including a-MSH, produces obesity in mice
and humans (Krude et al., 1998). Likewise, mutation inthe convergence of several prior lines of investigation.
The dominant obesity syndrome of the Ay mouse was neuropeptide processing enzymes PC-1 and carboxy-
peptidase E cause complex obesity syndromes in hu-shown to be due to a gene rearrangement causing ec-
topic expression of the coat color regulating protein mans and mice respectively, very likely at least in part
through effects on POMC processing (Reviewed inagouti (Bultman et al., 1992). Through transgenic and
pharmacologic experiments, it became apparent that Barsh et al., 2000). Very recently, targeted deletion of
the MC3R, a closely related receptor also restrictedagouti produced obesity by antagonizing the action of
a-MSH on MCR4s within the brain (Lu et al., 1994; Fan et largely to the brain, was shown to produce obesity in
mice (Butler et al., 2000). Interestingly, the obesity fromal., 1997; Ollmann et al., 1997; Graham et al., 1997), thereby
mimicking the hypothalmic agouti homolog AgRP. this lesion occurs without the hyperphagia seen in MC4R
mutants, and may be associated with a loss of lean bodyGene deletion of the MC4R causes obesity in mice,
and mice heterozygous for the knockout allele have mass as well as increased adiposity. Thus, these two
melanocortin receptors can cause obesity through dis-moderate obesity as well (Huszar et al., 1997). Remark-
ably, 4%–5% of severe human obesity appears to be tinct physiologic mechanisms.
Pathways Downstream of Melanocortin Receptorsdue to mutation at this locus, and most affected humans
have a single mutant allele, which causes obesity The identification of a leptin-regulated melanocortin
pathway provides a molecular and neuroanatomic linkthrough haploinsufficiency, rather than a dominant-neg-
Review
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between peripheral signals and CNS circuits, but leaves identified. In addition to neuropeptides and transmitters,
the function of these circuits is also influenced by meta-open the question of how these melanocortin signals
produce downstream effects on appetite, energy expen- bolic fuels. Neurons in the hypothalamus that respond to
changes in glucose levels (low brain glucose promotesditure, and neuroendocrine function. Several possible
mechanisms are emerging. In one model, leptin-regu- feeding) may be the same as, or functionally linked to
those neurons that respond to leptin and express thelated arcuate melanocortin nerve terminals project onto
neurons within the paraventricular hypothalamic nu- peptides discussed above. A role for lipid mediators
in metabolic sensing may be suggested by the recentcleus (PVN) that have previously been described to re-
spond in vivo to changes in nutritional status and leptin observation that inhibitors of fatty acid synthase po-
tently inhibit food intake through actions in the brainlevels. The PVN can be viewed as a motor arm of the
hypothalamus, as it regulates pituitary hormone secre- (Loftus et al., 2000).
The neurotransmitters norepinephrine, dopamine andtion via specific neuropeptides released by projections
to the median eminence, and regulates autonomic activ- serotonin are well known to be involved in central energy
balance circuits. Serotonergic neurons within the caudality via projections to autonomic preganglionic neurons.
One example is the TRH neuron in the PVN that regulates brainstem project widely within the brain, and drugs that
increase serotonergic signaling suppress food intakethe pituitary–thyroid axis. TRH expression within the
PVN is regulated through both melanocortin inputs from and have been used to treat obesity. Mice with deletion
of the 5HT2c serotonin receptor subtype have modestthe arcuate nucleus acting through MC4Rs on TRH neu-
rons, and by direct action via leptin receptors on these obesity (Nonogaki et al., 1998). Leptin increases seroto-
nin turnover, suggesting that these pathways can con-cells (reviewed in Flier et al., 2000). Similar mechanisms
may account for leptin effects on other PVN neurons verge, but 5HT2C-deficient mice retain an anorectic re-
sponse to leptin.that influence endocrine status, autonomic function, or
appetite. A second and parallel model involves direct The Return of Insulin
Although the discovery of leptin overshadowed earlierprojection of these arcuate melanocortinergic neurons
(AgRP and a-MSH) onto neurons within the lateral hypo- interest in the role of insulin as a central regulator of
energy balance, the venerable hormone has made athalamus that express the orexigenic neuropeptides
MCH and orexin/hypocretin (Elias et al., 1999). MCH, comeback. Not only is insulin a prominent positive regu-
lator of leptin expression in the fat cell, but the mildthe expression of which was discovered to be upregu-
lated in ob/ob hypothalami, stimulates food intake (Qu obesity in mice with neuron-specific deletion of the insu-
lin receptor (Bruning et al., 2000) or the insulin receptoret al., 1996). Deletion of the MCH gene causes a lean
phenotype (Shimada et al., 1998), and transgenic over- substrate IRS-2 (Burks et al., 2000), support the idea
that insulin and leptin may cooperate in central pathwayexpression promotes obesity. The first two models pro-
pose direct actions of melanocortins on TRH or MCH regulation. It will be important to determine whether
leptin and insulin signaling pathways converge on someneurons. Additional mechanisms are likely to exist, since
electrophysiologic evidence supports melanocortiner- of the same target cells, and by what mechanisms these
signaling pathways might interact.gic neurons projecting to GABAergic interneurons in
the PVN that are proposed to serve as integrators of Leptin Resistance: Hard Wired or Acquired?
As discussed above, most obese humans and rodentsnumerous inputs (Cowley et al., 1999). It is likely that all
of these mechanisms exist in concert. develop obesity despite high leptin levels, and adminis-
tration of additional leptin fails to reverse the obeseOther Neuropeptides and Neurotransmitters
The melanocortin system, although extremely impor- state. It is possible that “leptin resistance” arose through
evolution to permit energy storage in times of plenty.tant, is not the only neuropeptide system involved in
weight regulation. NPY acts through several species of This still leaves open the question of mechanism. One
potential mechanism involves a limitation of leptin trans-GPCRs to regulate energy balance, and PVN neurons
(either interneurons or neurons such as TRH neurons) port across the blood brain barrier, which may operate
through alternative splice variants of the leptin receptormay be sites where melanocortin and NPY signals are
integrated. Although NPY2/2 mice feed normally and highly expressed in brain microvessels. This mechanism
is supported by the ability of leptin injected directlyhave normal body weight, NPY deficiency ameliorates
obesity and other features of ob/ob mice, indicating into the brain to both suppress food intake and induce
hypothalamic signaling more effectively than leptin in-that NPY is necessary for the full response to leptin
deficiency (Erickson et al., 1996a, 1996b). CART is ex- jected by the peripheral route in mice with diet-induced
obesity (Van Heek et al., 1997; El-Haschimi et al., 2000).pressed widely, and is coexpressed in many leptin-regu-
lated arcuate POMC neurons. Among several projec- The molecular basis for this limitation is not yet defined.
Leptin signaling within the hypothalamus may also betions, leptin regulated CART neurons in the arcuate
nucleus project to autonomic sites in the spinal cord, impaired in the obese state. In susceptible C57Bl mice
with obesity induced by high fat diet, this signaling de-providing a possible link to autonomic pathways (Elias
et al., 1998). Many other neuropeptides, including CRH, fect is acquired as obesity develops (El-Haschimi et al.,
2000). Leptin resistance in these common states is notGHRH, and galanin have been described to participate
in these regulatory pathways, and most are beyond the complete, however, since obesity is much less severe
than seen in states of absent ligand or receptor, andscope of this review. Ghrelin is a peptide expressed in
stomach and brain that was originally identified through these mice lack several features, such as neuroendo-
crine defects, that characterize mice completely lackingits actions on the growth hormone axis. It is now clear
that ghrelin promotes hyperphagia and obesity through leptin or leptin receptors. This would make good evolu-
tionary sense, since modifications of leptin action de-actions in the brain, possibly on NPY neurons (Tschop
et al., 2000). It is likely that additional peptides will be signed to permit energy storage would be best designed
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to avoid the drastic consequences of starvation that and small biological impact of a given variation have led
result from total leptin lack. Currently, we do not under- to inconsistent findings (e.g., the W64R variation in the
stand the details of leptin signaling and targets that b3 adrenergic receptor) (Reviewed in Barsh et al., 2000).
result in such discordant effects.
Leptin Signaling and Resistance Control of Energy Expenditure—
Leptin receptors are members of the class I cytokine Adaptive Thermogenesis
receptor family that utilize associated Jak kinases for The components of energy expenditure that can be
signal transduction (Tartaglia, 1997). The best studied readily altered, i.e., physical activity and adaptive ther-
aspect of leptin signaling is the Jak-dependent activa- mogenesis, are of particular interest in the control of
tion of the STAT 3 pathway, and subsequent regulation obesity. Since physical activity is more properly the
of target gene expression. It is also clear that leptin also realm of fitness gurus and psychologists, we will con-
induces, via Jak, activation of the MAPkinase pathway, centrate here on describing the current state of scientific
one mechanism for which involves the participation of thinking about adaptive thermogenesis. Work in this
the phosphatase SHP-2. It has not yet been determined area has centered on two main aspects: the neural cir-
whether distinct effects of leptin, including rapid effects cuitry that activates thermogenesis and the peripheral
on ion channel activity, require specific downstream ef- tissues that actually oxidize fuels.
fector mechanisms. The control of cytokine signaling One might have assumed that neural pathways that
involves negative feedback signals. SOCS-3 is a mem- control food intake and energy expenditure are com-
ber of one such family of negative regulatory proteins pletely distinct. However, both naturally occurring and
that is induced in leptin responsive cells by leptin signal- targeted genetic lesions in mice have indicated that
ing pathways, and can serve as a marker of cells re- these pathways are tightly interrelated. Mutations in lep-
sponding directly to leptin (Bjorbaek et al., 1998, 1999). tin and the leptin receptor, MCR4 and MCH all strongly
SOCS-3 inhibits leptin signaling by actions at the level influence both food intake and energy expenditure in
of Jak as well as through binding to the receptor itself a coherent way, so that fat storage is increased (or
(Bjorbaek et al., 2000). It is not yet clear whether endoge- decreased) via both of these major components of the
nous SOCS-3, or other regulators such as the STAT energy balance equation. Conversely, exogenous ad-
inhibitors PIAS-1/3 are responsible for leptin resistance ministration of leptin to leptin-deficient mice decreases
in obesity. Since leptin and insulin may have some com- food intake, but also keeps energy expenditure at a
mon sites of action, it is interesting to note that insulin higher level than would be expected for that degree of
signaling may also be antagonized by SOCS family food intake (Friedman and Halaas, 1998). Clearly, a ma-
members (Emanuelli et al., 2000). jor component of this brain-driven thermogenesis is de-
Genes and the Environment pendent on output from the sympathetic nervous sys-
The cloning of genes responsible for the previously tem to the peripheral tissues, especially brown fat and
known rodent monogenic obesities (e.g., ob, db, and skeletal muscle. While the role of the sympathetic ner-
Ay) has led to the identification of regulatory pathways, vous system in activating brown adipose tissue (BAT)-
and has indicated that these pathways are preserved in
mediated thermogenesis via b-adrenergic receptors
humans. The realization that severe obesity in humans
and cyclic AMP (cAMP) is well established, the role in
can result from mutations in the ob, db, and MC4R loci,
skeletal muscle is still a matter of some conjecture. That
with the latter accounting for 4%–5% of severe cases,
catecholamines infused into skeletal muscle increaseindicates the importance of these systems. However,
energy expenditure without the performance of work isthe rarity of these mutations highlights the fact that most
quite clear (Simonsen et al., 1992); whether the keyhuman obesity is polygenic rather than Mendelian, con-
step(s) involves control of vascular tone, or regulationtrolled by many genetic loci. Since the prevalence of
of specific components involved in fuel oxidation is notobesity is increasing in industrialized societies, it is ap-
established. However, the fact that mice genetically ab-parent that many of these genes must confer suscepti-
lated for the production of catecholamines show greaterbility to environmental factors, such as availability of
sensitivity to cold than do mice mutated in UCP-1 (Ener-food and composition of diets, and response to exer-
back et al., 1997; Thomas and Palmiter, 1997) (see be-cise, or lack of it. Efforts are underway to map genes that
low), suggests strongly that other, non-BAT pathwaysconfer susceptibility to diet induced obesity in inbred
of thermogenesis are important.strains of mice. Responsible genes may be part of al-
The mitochondrion is the cellular furnace where fuelsready identified pathways, or may be previously un-
(dervied from fatty acids and glucose) are oxidized andknown components of known pathways. In human pop-
energy is either stored in the high-energy phosphateulations, genome scans for linkage with obesity-related
bonds of ATP or is released as heat. Figure 3 illustratesphenotypes are ongoing in many populations. One locus
that as electrons are passed down, the energy gradientshowing linkage to leptin levels in two populations is on
of the electron transport chain, protons are pumped outthe short arm of chromosome 2 at band 21 (2p21), a
of the inner matrix of the mitochondria, generating anregion that includes the POMC gene (Comuzzie et al.,
electrochemical gradient across the inner mitochondrial1997). In addition to studies based on linkage, or detec-
membrane. These protons have two probable fates: astion of mutations in rare Mendelian disorders, many
described by Mitchell, they can reenter the mitochon-studies have sought evidence through a candidate gene
drial matrix through ATP synthase, driving the synthesisapproach. Although this approach can be successful
of ATP. ATP production is thus linked to the consump-when the candidate has a fundamental role (e.g., the
tion of oxygen and this is referred to as coupled respira-MC4R locus), the list of plausible candidates is very
long, and factors such as heterogeneity of populations tion. Alternatively, protons may “leak” back across the
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Figure 3. Mitochondrial ATP Metabolism and Thermogenesis through Proton Transport
Fatty acids and glucose are oxidized to generate NADH and FADH2, which donate electrons to the electron transport chain. Ubiquinone (Q)
shuttles electrons from both complexes I and II to complex III, whereas cytochrome c (C) shuttles electrons from complex III to complex IV.
Molecular oxygen (O2) is the terminal electron acceptor. Protons are pumped out by complexes I, III, and IV of the electron transport chain,
which creates a proton electrochemical potential gradient (DmH1). Protons may reenter the mitochondrial matrix through the F0/F1-ATPase,
with energy being used to generate ATP from ADP and Pi. Protons may also reenter through an uncoupling protein (UCP), or the membrane
itself, with energy being released in the form of heat. Abbreviations: complex I, NADH-ubiquinone oxidoreductase; complex II, succinate-
ubiquinone oxidoreductase; complex III, ubiquinone-cytochrome-c oxidoreductase; and complex IV, cytochrome-c oxidase.
inner mitochondrial membrane in a manner not linked (Clapham et al., 2000), several pieces of data have sug-
gested that the role of these proteins in energy balanceto ATP production. This uncouples energy storage from
oxygen consumption and is referred to as uncoupled and physiology may be complex. Most strikingly, fast-
ing, which is associated with a major reduction in totalrespiration. A certain degree of “leak” is an inherent
property of several biological membranes, but this pro- body energy expenditure, is associated with an increase
in the expression of UCP2 and UCP3 mRNA (Boss etton translocation can be greatly accelerated by the ac-
tion of uncoupling proteins (UCPs), which function as al., 2000). More recently, mice deficient in UCP2 or UCP3
have been made and neither strain shows a significantspecialized proton channels not linked to ATP produc-
tion. In uncoupled respiration, energy is released as heat propensity for hypothermia, reduced energy expendi-
ture, or obesity (Arsenijevic et al., 2000; Gong et al.,because these leaks, whether catalyzed by UCPs or
not, disrupt the cycle and result in fuel oxidation in the 2000; Vidal-Puig et al., 2000). Together, these data sug-
gest that none of the known UCPs alone has clear-cutabsence of work.
The thermogenic function of BAT and UCP-1 have anti-obesity effects. Of course, it is still entirely possible
that they can functionally compensate for each other inbeen extensively studied. Interestingly, mice genetically
reduced in BAT are prone to obesity while mice deficient targeted mutations, so combined mutations must be
created before absolute conclusions can be drawn.in UCP-1 have not shown a propensity to gain weight
(Lowell and Flier, 1997). On the other hand, mice lacking Where does this leave us with regard to mechanisms
of energy expenditure and adaptive thermogenesis inUCP-1 are extremely sensitive to cold. These data sug-
gested that there may well be additional mechanisms large animals like humans, where the mass of skeletal
muscle vastly exceeds that of brown fat? There arethat can control energy expenditure and metabolic rates
in addition to UCP-1, even in BAT. several possibilities. First, since the inner membrane
of mitochondria itself leaks protons, it is possible thatThe last several years have seen the identification of
two other members of the UCP family: UCP2, widely adaptive thermogenesis is controlled in an important
way by regulation of mitochondrial biogenesis and elec-expressed in many tissues, and UCP3, expressed pri-
marily in BAT and skeletal muscle. Hopes have been tron transport rates themselves. An increased electron
transport system will drive a greater membrane potentialhigh that these proteins may play major roles in whole
body energy expenditure outside of BAT, particularly in as more protons are pumped out. It is well recognized
that this greater membrane potential alone will result inskeletal muscle (Kozak and Harper, 2000; Ricquier and
Bouillaud, 2000). While it seems clear that these proteins increased proton leak and increase uncoupled respira-
tion even in the absence of a UCP. Hence, UCP1 maycan uncouple oxidative phosphorylation at a cellular
level and UCP-3 can protect against obesity when be a very specialized molecule for defense against cold
in small mammals, but large animals with smaller surfacegreatly overexpressed in the skeletal muscle of mice
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to volume ratios may simply be able to use the inherent BAT and skeletal muscle. This cold induction is the result
properties of biological membranes to regulate heat pro- of the sympathetic nervous system acting via b-3 adren-
duction and adaptive thermogenesis. ergic receptors and cyclic cAMP (Boss et al., 1999).
Alternatively, one can imagine that other “futile-cycles” When PGC-1 is expressed in white fat or skeletal muscle
can serve as specific thermogenic mechanisms regulat- cells, a broad program of thermogenesis begins, includ-
ing metabolic rates (reviewed in Lowell and Spiegelman, ing induction of mitochondrial biogenesis, expression
2000). From a bioenergetic perspective, there is nothing of an uncoupling protein (UCP-1 or UCP-2 in fat cells
magical about a futile cycle of proton pumping that could or muscle, respectively), and an increase in total cellular
not, in principle, be accomplished through other means. respiration. From the perspective of the adipose lineage,
Key examples exist—deep diving fish have a specially PGC-1 expression makes white fat cells more like brown
modified periocular muscle that is relatively devoid of cells (Puigserver et al., 1998; Wu et al., 1999).
cotractile elements. Depolarization of these muscle cells PGC-1 can interact with and coactivate a large num-
causes release of calcium from the sarcoplasmic reticu- ber of transcription factors in addition to PPARg. Indeed,
lum. ATP is then consumed by the Ca21-ATPase, which PGC-1 can interact with most nuclear hormone recep-
pumps calcium back into the sarcoplasmic reticulum in tors (Puigserver et al., 1998; Knutti et al., 2000; Tsherepa-
a futile ion cycle. Ca21 cycling results in fuel oxidation nova et al., 2000). PGC-1 docks on some receptors,
without work being performed, thus generating heat. such as PPARg or PPARa, in a non-ligand-dependent
Mammals apparently have a potential to cycle calcium way and interacts with other receptors, such as the
in a similar way. Humans or pigs carrying mutations in estrogen receptor or glucocorticoid receptor, in a li-
the ryanidine receptor, the Ca21 release channel of the gand-dependent manner. The ability of PGC-1 to pro-
sarcoplasmic reticulum, release Ca21 in response to mote mitochondrial biogenesis appears to be due to its
stress or an anesthesia. This results in futile calcium ability to turn on the expression of both NRF-1 and
cycling and an intense thermogenesis that can be fatal. NRF-2, and to directly coactivate NRF-1 through pro-
Such a mechanism is also observed in cold-adapted tein–protein interactions (Wu et al., 1999). PGC-1 loses
birds, suggesting that this could play a role in adaptive most or all of its ability to activate mitochondrial biogen-
thermogenesis of other animals including humans. esis in the presence of a dominant-negative allele of
Transcriptional Control of Thermogenesis NRF-1. The ability of PGC-1 to activate the UCP-1 en-
Several key steps of mammalian thermogenesis, partic- hancer appears linked to the coactivation of PPARg,
ularly mitochondrial biogenesis and the expression of since PGC-1’s activity on this enhancer is ablated by a
UCP1, have been the subject of considerable study at mutation of the PPARg binding site.
the transcriptional level. Much of this effort has been It is interesting to note that while most biological pro-
focused on the role of cAMP in inducing these pro- grams studied to date show dominant regulation at the
cesses. level of the DNA binding transcription factor, adaptive
The UCP1 gene has an enhancer element that is both thermogenesis shows remarkable regulation at the level
brown fat selective and responsive to cyclic AMP stimu- of the coactivator. Presumably, this is due to the fact that
lation (Cassard-Doulcier et al., 1993; Kozak et al., 1994). this complex program, which involves multiple tissues,
Perhaps surprisingly, there have been no reports to date hormone sensitivities, and transcription factors, requires
of brown fat–specific transcription factors regulating more genetic coordination than can be achieved at the
this enhancer. Rather, there are binding sites for PPARg, level of a single DNA binding factor. A crucial question
an important regulator of both white and brown fat cell that must be answered is whether expression of PGC-1
differentiation, a potential thyroid hormone response el- itself determines or helps to determine whether cells
ement (TRE), a retinoic acid response element (RARE), are white fat cells or brown fat cells. Similarly, skeletal
and several potential cyclic-AMP response elements muscle fibers come in two types: slow twitch (type 1)
(Sears et al., 1996). As defined in knockout mice, the
that are very oxidative and are very rich in mitochondria,
only transcriptional component shown to be required
and fast twitch (type 2), which have a more glycolytic
for BAT development is PPARg (Barak et al., 1999).
metabolism and have fewer mitochondria. Since slowThe genes of mitochondrial biogenesis and the respi-
twitch fibers are more oxidative, a greater number ofratory chain have been intensively studied, leading to
these versus fast twitch fibers could well alter total bodythe discovery of nuclear respiratory factor (NRF)-1 and
energy expenditure. The role of PGC-1 in both of these-2 as key transacting elements. The vast majority of
cell biological decisions must be determined via gain-mitochondrial genes that are encoded in the nuclear
and loss-of-function experiments in mice.genome have functional binding sites for NRF-1, NRF-2,
or both (Virbasius and Scarpulla, 1994; Gugneja et al.,
Linking Lipogenesis and Adipogenesis—A Role1996). The NRFs, in turn, regulate mitochondrial tran-
for ADD1/SREBP1?scription factor A (mtTFA), which directs the transcrip-
A chronic imbalance between energy intake and energytion and replication of the mitochondrial genome. How
expenditure can lead to an increase in both fat cell sizeexternal stimuli, such as cold or diet, affect the amount
and fat cell number. Recent studies have suggestedor activity of NRFs has not been well studied.
a mechanism that can potentially link lipogenesis andRecently, a transcriptional component, PPARg coacti-
adipogenesis.vator (PGC)-1, that can coactivate and coordinate many
Several recent reviews have been written on the tran-transcription factors that participate in multiple aspects
scriptional control of adipogenesis (Mandrup and Laneof adaptive thermogenesis has been described (Puig-
1997; Rosen et al., 2000), so the details of this processsever et al., 1998). PGC-1 is expressed in multiple tis-
sues of rodents and man, but is cold inducible only in will not be discussed here. What now seems very clear
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ing domain of the yeast Gal4 (Kim et al., 1998b). It is
most likely that this occurs via transcriptional control of
the enzymes required to make an endogenous, agonist
ligand of PPARg. This possibility is further strengthened
by the fact that ADD1/SREBP1 controls several known
enzymes of fatty acid metabolism, and all known biologi-
cal ligands for PPARg are fatty acids or fatty acid deriva-
tives. The identity of the precise PPARg ligands regu-
lated by ADD1/SREBP1 are unknown but of great
interest.
Therapeutic Issues and Opportunities
It is estimated that 300,000 people die annually in the
United States as a result of obesity, and most of these
deaths are due to the effect of obesity in promoting
diabetes, hypertension, cardiovascular disease, and
cancer (Kopelman, 2000). Therapy based on nutritional
Figure 4. The Transcriptional Control of Adipogenesis Involves the and behavioral counseling is capable of producing use-
Activation of Several Families of Transcription Factors
ful weight loss with attendant reduction of morbid con-
These proteins are expressed in a network in which C/EBPb and
sequences, but weight loss is usually partial, and almostC/EBPd are detected first, followed by PPARg, which in turn acti-
always temporary. Existing pharmaceuticals target cen-vates C/EBPa and a broad program of adipogenesis. C/EBPa exerts
tral serotonergic and adrenergic pathways, or inhibitpositive feedback on PPARg to maintain the differentiated state.
ADD1/SREBP1c is regulated by insulin in fat and can activate PPARg intestinal fat absorption, and are of limited efficacy (Bray
by inducing its expression as well as by promoting the production and Tartaglia, 2000). The approval of new therapies for
of an endogenous PPARg ligand. ADD1/SREBP1c also activates obesity will require high standards for safety for several
many genes of lipogenesis. All of these factors contribute to the
reasons. These include the likely need for chronic ther-expression of genes that characterize the terminally differentiated
apy, the history of toxicity of serotonergic drugs, con-phenotype.
cern about abuse by those seeking weight loss for purely
cosmetic reasons, and the common, if erroneous view
that obese individuals should be able to lose weightis that fat cell differentiation is regulated by the function
and interplay between several members of the C/EBP through personal effort rather than drugs. Despite these
concerns, new insights into the molecular and physio-transcription factor family, and the nuclear receptor
PPARg. This is summarized in Figure 4. A key question logic pathways that underlie regulated energy balance
have created many opportunities for drug discovery inhas been, how can a chronic imbalance between energy
intake and energy expenditure trigger both fat cell hyper- the obesity field.
Obesity Therapy and Energy Balancetrophy and fat cell hyperplasia? There is no doubt con-
cerning the dominant role played by insulin in the fed and A successful obesity therapy must impact energy intake,
energy expenditure, or both. Since several key targetschronically overfed states. There have been a number of
transcription factors that can potentially regulate differ- (e.g., leptin receptors and MC4Rs) coordinately increase
energy expenditure and suppress energy intake, it isent genes of lipogenesis, but ADD1/SREBP1, a member
of the basic helix-loop-helix family of factors, can acti- possible to envisage therapies that accomplish both
effects. Therapies that target energy intake or expendi-vate a broad program of genes involved in fatty acid
and triglyceride metabolism in both fat and liver (Kim ture alone may initially produce weight loss, but the
existence of a homeostatically defended feedback loopand Spiegelman, 1996; Shimano et al., 1996). Impor-
tantly, the expression of ADD1/SREBP1 is regulated by would be expected to resist further weight loss and limit
efficacy. For example, if weight loss resulted in a fall infasting and feeding and this was shown to be regulated
by insulin in fat (Kim et al., 1998a). Subsequent studies leptin levels, this might resist further weight loss through
effects on central pathways to increase hunger and de-showed that insulin also regulated this factor in liver
(Shimomura et al., 1999). ADD1/SREBP1 has been shown crease energy expenditure. It is possible that combina-
tion therapies aimed at two or more distinct steps in theto be synthesized as a membrane-bound precursor that
must be released by proteolysis (Brown and Goldstein, pathway of energy balance might be necessary, as is
often the case in disorders such as hypertension and1998; Brown et al., 2000). Cleavage of the ADD1/
SREBP1 does not seem to be regulated by cholesterol type II diabetes. Finally, we may eventually target spe-
cific therapies to individual lesions underlying obesitylevels, unlike SREBP2, and the pathway responsible for
this activation for ADD1/SREBP1 is still unclear. in specific cases. It is already evident that rare patients
lacking leptin respond dramatically to this hormone,ADD1/SREBP1 can also accelerate adipogenesis. This
factor alone cannot promote differentiation of non-adipo- while patients lacking the receptor will be totally unre-
sponsive, and patients with common obesity have agenic fibroblasts, but when coexpressed on fibroblasts
expressing PPARg, cell differentiation is enhanced (Kim limited response.
Therapies Aimed at Suppressing Food Intakeand Spiegelman, 1996). Subsequent studies have shown
that ADD1/SREBP1 can enhance the transcriptional ac- Despite disappointing results of initial clinical trials, it
may be possible to find strategies for administering lep-tivity of PPARg, and indeed, can activate an isolated
ligand binding domain of PPARg fused to the DNA bind- tin to patients with common obesity that will favor weight
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loss or maintain weight loss brought about by other in which adipocyte lipase is constitutively increased, is
means (Reviewed in Mantzoros and Flier, 2000). The lean despite increased food intake, and has increased
phenomenon of leptin resistance motivates the search metabolic rate; absence of perilipin dramatically re-
for small molecule leptin receptor agonists that might duces obesity of db/db (Martinez-Botas et al., 2000).
bypass the blood brain barrier, or receptor sensitizers. Although some aspects of the phenotype, such as in-
Several cytokines suppress appetite and promote weight creased energy expenditure, are yet to be explained,
loss. Ciliary neurotrophic factor (CNTF) is a neurocyto- perilipin may be an interesting drug target.
kine that has been found to reverse obesity in leptin
resistant db/db mice, possibly by activating JAK/STAT Conclusions
signaling pathways in leptin responsive neurons (Gloa- Obesity and its antithesis, starvation, have always been
guen et al., 1997). Therapeutic trials in obesity are under- part of the human condition, and for most of human
way. Several gut-derived peptides that influence satiety, history have been seen as resulting simply from avail-
such as cholecystokinin (CCK) and glucagon-like pep- ability of food, or acts of will related to attainment of
tide-1 (GLP-1) (Flint et al., 1998), or small molecule ago- desired body shape. Although this view persists in some
nists for their receptors, are therapeutic candidates. Per- quarters to this day, the last 5 years of the millennium
haps the greatest pharmaceutical effort is addressing have witnessed a dramatic increase in our understand-
the central neuropeptide pathways. Knockout experi- ing of the biology of regulated energy balance and body
ments for NPY and its several receptors suggest a robust weight. Physiologic pathways whose existence was de-
capacity for redundancy of these pathways, but small bated 10 years ago are now being characterized in mo-
molecule antagonists for NPY Y-1 and Y-5 receptors lecular detail, with immediate implications for under-
have shown preclinical promise, and are under develop- standing of pathogenesis of human obesity and other
ment (Gehlert, 1999). It should be stressed that the phe-
disorders of energy balance. The roadmap provided by
notypes of gene knockout mice may not always predict
these advances establishes a clear direction for future
the response to inhibitors of the same pathway. Al-
research, but critical details remain to be discovered,
though less advanced than NPY antagonists, great effort
and therapeutic applications remain to be realized. In
is being expended to develop MC4R agonists and antag-
particular, the mechanisms by which environmental fac-
onists for the MCH receptor.
tors, including diet and exercise, interact with molecularTherapies Aimed at Increasing Energy Expenditure
pathways in the common polygenic forms of obesity isThe fall in energy expenditure during weight loss limits
largely unknown at present. Insights from the sequenc-the efficacy of diets, and therapies that could prevent
ing of the human genome and the coming advances inthis, or simply increase energy expenditure, would pro-
proteomics are likely to fuel the next wave of progress.mote weight loss. Thyroid hormone promotes thermo-
It is likely that both new genes and new regulatory path-genesis by as yet uncertain mechanisms, and it is well
ways will be identified. It may seem unlikely that theknown to clinicians that increased thyroid hormone pro-
recent wave of progress can be matched in the earlyduces weight loss, but other adverse effects of thyroid
years of the current millennium, but we would notexcess including loss of lean body mass prevent its use
choose to make that bet.as an obesity treatment. b-3 adrenergic agonists are
highly effective at promoting thermogenesis and weight
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